Reporting owner · Q3 2026 · CIK 1756991

Goncalves Joana: insider trades.

Goncalves Joana reported 19 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 13 sales ($2.1M), across 1 company.

Transactions
19
Purchases (P)
0
Sales (S)
13
Companies
1
Name as filed
Goncalves Joana

Companies

CompanyRelationshipTransactions
Oruka Therapeutics, Inc. (ORKA)Officer · Chief Medical Officer19

Transactions

19 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-15Oruka Therapeutics, Inc.S947$95.7131,771Form 4
2026-09-15Oruka Therapeutics, Inc.S1,366$92.9932,818Form 4
2026-09-15Oruka Therapeutics, Inc.S3,150$92.0334,184Form 4
2026-09-15Oruka Therapeutics, Inc.S2,384$91.137,334Form 4
2026-09-15Oruka Therapeutics, Inc.M3,500$7.839,718Form 4
2026-09-15Oruka Therapeutics, Inc.M3,500$6.8436,218Form 4
2026-09-15Oruka Therapeutics, Inc.S100$94.2232,718Form 4
2026-08-17Oruka Therapeutics, Inc.M3,500$6.8436,218Form 4
2026-08-17Oruka Therapeutics, Inc.S300$110.5238,518Form 4
2026-08-17Oruka Therapeutics, Inc.S900$109.6538,818Form 4
2026-08-17Oruka Therapeutics, Inc.S2,480$112.5632,718Form 4
2026-08-17Oruka Therapeutics, Inc.S3,320$112.0135,198Form 4
2026-08-17Oruka Therapeutics, Inc.M3,500$7.839,718Form 4
2026-07-15Oruka Therapeutics, Inc.S300$87.2532,718Form 4
2026-07-15Oruka Therapeutics, Inc.M3,500$6.8436,218Form 4
2026-07-15Oruka Therapeutics, Inc.M3,500$7.839,718Form 4
2026-07-15Oruka Therapeutics, Inc.S400$84.3739,318Form 4
2026-07-15Oruka Therapeutics, Inc.S2,497$85.8636,821Form 4
2026-07-15Oruka Therapeutics, Inc.S3,803$86.6833,018Form 4

Questions

What stock did Goncalves Joana buy or sell?

Goncalves Joana reported 19 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 13 sales ($2.1M), across 1 company.

Is Goncalves Joana the same person as other filers with this name?

This page covers SEC CIK 1756991 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/goncalves-joana-1756991.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.